Knockdown of Stat3 Expression Using RNAi Inhibits Growth of Laryngeal Tumors in Vivo.

Li-fang Gao,Lian-ji Wen,Hao Yu,Ling Zhang,Yan Meng,Yue-ting Shao,De-qi Xu,Xue-jian Zhao
DOI: https://doi.org/10.1111/j.1745-7254.2006.00277.x
IF: 7.169
2006-01-01
Acta Pharmacologica Sinica
Abstract:Aim: To study the effect of pSilencer 1.0-U6-siRNA-stat3 on the growth of human laryngeal tumors in nude mice. Methods: Hep2 cells were transplanted into nude mice, then at the time of tumor formation, growth rates were observed. After the tumor formed, pSilencer 1.0-U6-siRNA- stat3 was injected. Tumor volumes were calculated, and growth curves were plotted. Representative histological sections were taken from mice bearing transplantation tumors in both treated and control groups, and start3 , pTyr-stat3 , Bcl-2 , cyclin D1 , and survivin expression were detected by Western blotting. survivin mRNA levels were detected by Northern blotting, hematoxylin and eosin staining and terminal deoxyribonucleotidyl transferase-mediated dUTP-digoxigenin nick end-labeling (TUNEL) assay to confirm the apoptosis of tumors. Results: In nude mice, pSilencer 1.0-U6-siRNA- stat3 significantly suppressed the growth of tumors compared with controls ( P <0.01). In suppressed stat3 expression, and downregulated BcL2, cyclin D1 , and survivin expression within the tumor. This significantly induced apoptosis of the tumors. Conclusion: pSilencer 1.0-U6-siRNA- stat3 was able to inhibit the growth of transplanted human laryngeal tumors in nude mice and induce apoptosis.
What problem does this paper attempt to address?